This inventor holds 1 USPTO granted patent. Top assignee: Hemocorm Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Tony Richard Johnson: Innovator in Therapeutic Delivery of Carbon Monoxide
Introduction
Tony Richard Johnson is a pioneering inventor based in Sheffield, GB, known for his significant contributions to the pharmaceutical field. With a particular focus on innovative methods for therapeutic delivery, his work is aimed at enhancing medical treatments that involve carbon monoxide.
Latest Patents
Tony holds a noteworthy patent titled "Therapeutic delivery of carbon monoxide." This patent encompasses compounds, pharmaceutical compositions, and methods designed for the therapeutic delivery of carbon monoxide to humans and other mammals. His innovation utilizes transition metal complexes featuring at least a substituted cyclopentadienyl, indenyl, or fluorenyl ligand, along with two or more carbonyl ligands. This technology represents a significant advancement in drug delivery systems.
Career Highlights
As a key member of Hemocorm Limited, Tony has played a pivotal role in the development of novel therapeutic approaches. His expertise in pharmaceutical formulations and delivery mechanisms has established him as a valuable asset to the company and the broader scientific community.
Collaborations
Tony collaborates closely with notable coworkers, including Roberto Angelo Motterlini and Brian Ernest Mann. Together, they contribute to important research initiatives that focus on the therapeutic potential of carbon monoxide, further establishing Hemocorm Limited as a leader in innovative medical solutions.
Conclusion
Tony Richard Johnson’s dedication to exploring the therapeutic applications of carbon monoxide showcases his inventive spirit and commitment to advancing healthcare. His patent stands as a testament to the impact of innovation on medical treatment, paving the way for future development in pharmacology and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile